Ilika begins trading on the OTCQX Best Market in the U.S.

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, is pleased to announce that trading in the Company’s ordinary shares will begin today on the OTCQX Best Market, in the United States, under the ticker symbol “ILIKF”. Ilika has upgraded to OTCQX from the Pink® market.

Trading on OTCQX is an important step for Ilika, in addition to the AIM listing it gives the business exposure to a wider audience of potential investors by easing cross-border trading for our US investors. By trading on the premium OTCQX, Ilika’s shares will be available to US investors during US working hours and priced in US dollars and has the potential to increase liquidity in Ilika’s shares on AIM. Ilika’s shares will continue to trade on the London Stock Exchange’s AIM market under the symbol “IKA”.

Graeme Purdy, Ilika plc CEO commented, “We are very pleased to be graduating to the OTCQX Market. This will provide our valued US investors with greater liquidity and execution services through OTCQX. It will also help us to build our visibility among US investors.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Search